The genus Euthycaelus Simon 1889 is diagnosed based on the examination of type-material and additional material from Venezuela and Colombia. The genus now includes: Euthycaelus colonicus Simon 1889, E. norae sp. nov., E. amandae sp. nov.; Euthycaelus steini Simon 1889 is transferred to Psalistops comb. nov. The genus Schismatothele Karsch 1879 is considered a senior synonym of Hemiercus Simon 1903. Schismatothele includes S. lineata Karsch 1879, S. inflata (Simon 1889) comb. nov., S. modesta (Simon 1889) comb. nov, and S. benedettii Panzera et al. 2011. Hemiercus proximus Mello-Leitão 1923, from Cubatão, São Paulo, Brazil, is transferred to Acanthoscurria proxima (Mello-Leitão 1923) comb. nov. Hemiercus kastoni Caporiacco 1955 is considered a species inquirenda pending the examination of the type material.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.11646/zootaxa.3795.3.3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Seven new species of the enigmatic spider family Paratropididae are described from Ecuador. All new species belong to the genus Paratropis: P. carcosita sp.
View Article and Find Full Text PDFThe genera and revisited with the description of a new species (Araneae, Salticidae) using digital specimen DOIs and nanopublications.
Biodivers Data J
September 2024
Naturalis Biodiversity Center, Leiden, Netherlands Naturalis Biodiversity Center Leiden Netherlands.
Background: Two Southeast Asian spider collections: that of Frances and John Murphy, now in the Manchester University Museum and the Deeleman collection, now at the Naturalis Biodiversity Center in Leiden constituted the basis of this analysis of Thorell, 1887 and related genera. The latter collection also includes many thousands of spiders obtained by canopy fogging for an ecological project in Borneo by A. Floren.
View Article and Find Full Text PDFGenome wide association study of clinical duration and age at onset of sporadic CJD.
PLoS One
July 2024
MRC Prion Unit at University College London (UCL), Institute of Prion Diseases, UCL, London, United Kingdom.
Article Synopsis
- Human prion diseases are unusual brain illnesses that can spread and cause quick changes in memory and thinking.
- The study looked at a specific type called sporadic Creutzfeldt-Jakob disease (sCJD), examining data from over 3,700 cases to understand how long the disease lasts and at what age it starts.
- Researchers found important genetic clues on chromosome 20 that can help understand how long people live with this disease, especially one specific genetic change that seems to have a big effect on survival time.
Young-GRAPPA 2023: The Future Is Bright.
J Rheumatol
October 2024
F. Proft, MD, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany;
Two years after its inception, Young Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (Y-GRAPPA) has established itself as a productive network for junior investigators and clinicians. The group's achievements in the last year include updating the educational GRAPPA slide library, the "Bring a Derm" campaign to expand the GRAPPA community to include more dermatologists, and the publication of multiple "Do Not Miss" newsletters covering the highlights on PsDs from the major international conferences (American Academy of Dermatology [AAD] Annual Meeting, European Alliance of Associations for Rheumatology [EULAR] Congress, European Academy of Dermatology and Venereology [EADV] Congress, and American College of Rheumatology [ACR] Convergence).
View Article and Find Full Text PDFThe ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.
Nat Commun
February 2024
Oncology R&D, AstraZeneca, Cambridge, UK.
The Ataxia telangiectasia and Rad3-related (ATR) inhibitor ceralasertib in combination with the PD-L1 antibody durvalumab demonstrated encouraging clinical benefit in melanoma and lung cancer patients who progressed on immunotherapy. Here we show that modelling of intermittent ceralasertib treatment in mouse tumor models reveals CD8 T-cell dependent antitumor activity, which is separate from the effects on tumor cells. Ceralasertib suppresses proliferating CD8 T-cells on treatment which is rapidly reversed off-treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!